Showing 1 - 8 of 8 Items
Showing 1 - 8 of 8 Items
Sort By: Relevance
Journal Article
|Research
1996-08-01 • International Journal of Epidemiology
1996-08-01 • International Journal of Epidemiology
BACKGROUND: Although endemic in parts of southern Sudan, visceral leishmaniasis (VL) had not been reported in Western Upper Nile (WUN) until an epidemic was confirmed in 1989. A combinat...
Journal Article
|Research
2003-02-01 • Tropical Medicine and International Health
2003-02-01 • Tropical Medicine and International Health
We compared an rK39 dipstick rapid test (Amrad ICT, Australia) with a direct agglutination test (DAT) and splenic aspirate for the diagnosis of kala-azar in 77 patients. The study was ca...
Journal Article
|Research
2000-05-01 • Tropical Medicine and International Health
2000-05-01 • Tropical Medicine and International Health
OBJECTIVE
To compare the outcome of treatment of Sudanese kala-azar patients treated under field conditions with either branded sodium stibogluconate (SSG) (Pentostam GlaxoWellcome) ...
To compare the outcome of treatment of Sudanese kala-azar patients treated under field conditions with either branded sodium stibogluconate (SSG) (Pentostam GlaxoWellcome) ...
Journal Article
|Research
2008-01-31 • Transactions of the Royal Society of Tropical Medicine and Hygiene
2008-01-31 • Transactions of the Royal Society of Tropical Medicine and Hygiene
We evaluated generic sodium stibogluconate (SSG) (International Dispensary Association, Amsterdam) versus Pentostam (sodium stibogluconate, GlaxoWellcome, London) under field conditions ...
Journal Article
|Research
1996-04-01 • Annals of Internal Medicine
1996-04-01 • Annals of Internal Medicine
OBJECTIVES
1) To determine the proportions of patients with visceral leishmaniasis who had various treatment outcomes when cared for under wartime conditions and with limited resourc...
1) To determine the proportions of patients with visceral leishmaniasis who had various treatment outcomes when cared for under wartime conditions and with limited resourc...
Journal Article
|Research
Liposomal Amphotericin B (AmBisome) in the Treatment of Complicated Kala-Azar Under Field Conditions
1995-07-01 • Clinical Infectious Diseases
1995-07-01 • Clinical Infectious Diseases
An open trial of liposomal amphotericin B (AmBisome [L-AmB]; Vestar, San Dimas, CA) for treatment of complicated visceral leishmaniasis was performed in Sudan. Forty-nine patients were t...
Journal Article
|Research
1992-10-01 • Annals of Tropical Medicine and Parasitology
1992-10-01 • Annals of Tropical Medicine and Parasitology
A combination of interview, serology and skin testing was used to investigate the status of apparently healthy villagers during a visceral leishmaniasis epidemic in southern Sudan. The n...
Journal Article
|Research
1993-09-01 • Journal of Infectious Diseases
1993-09-01 • Journal of Infectious Diseases
In a comparative trial of treatment in southern Sudan, visceral leishmaniasis was diagnosed by the following symptoms: fever for > 1 month, splenomegaly, and antileishmanial direct agglu...